These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11452455)
1. [Indications for allogeneic bone marrow transplantation (BMT) in adult acute myelogenous leukemia: matched-pair analysis in comparison with chemotherapy in patients achieving initial remission]. Sakura T Rinsho Ketsueki; 2001 May; 42(5):380-4. PubMed ID: 11452455 [No Abstract] [Full Text] [Related]
2. [Indication of allogeneic bone marrow transplantation (BMT) from HLA identical sibling in adult acute myeloblastic leukemia--comparative study of BMT and chemotherapy in patients with the first remission state. Nagoya BMT Group. Japan Adult Leukemia Study Group]. Morishima Y; Tanimoto M; Kodera Y; Miyawaki S; Hirabayashi N; Tomonaga M; Kojima H; Kobayashi T; Onozawa Y; Nitta M Rinsho Ketsueki; 1995 Jun; 36(6):517-23. PubMed ID: 7643444 [TBL] [Abstract][Full Text] [Related]
3. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission. Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073 [TBL] [Abstract][Full Text] [Related]
4. [Current situation and perspective for treatment of acute myelogenous leukemia in adults]. Fukushima T; Ueda T Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819 [TBL] [Abstract][Full Text] [Related]
5. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Tallman MS; Pérez WS; Lazarus HM; Gale RP; Maziarz RT; Rowe JM; Marks DI; Cahn JY; Bashey A; Bishop MR; Christiansen N; Frankel SR; García JJ; Ilhan O; Laughlin MJ; Liesveld J; Linker C; Litzow MR; Luger S; McCarthy PL; Milone GA; Pavlovsky S; Phillips GL; Russell JA; Saez RA; Schiller G; Sierra J; Weiner RS; Zander AR; Zhang MJ; Keating A; Weisdorf DJ; Horowitz MM Biol Blood Marrow Transplant; 2006 Feb; 12(2):204-16. PubMed ID: 16443518 [TBL] [Abstract][Full Text] [Related]
6. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia. Ayash LJ; Ratanatharathorn V; Braun T; Silver SM; Reynolds CM; Uberti JP Am J Hematol; 2007 Jan; 82(1):6-14. PubMed ID: 16986128 [TBL] [Abstract][Full Text] [Related]
7. Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy. Brandwein JM; Gupta V; Schuh AC; Schimmer AD; Yee K; Xu W; Messner HA; Lipton JH; Minden MD Am J Hematol; 2008 Jan; 83(1):54-8. PubMed ID: 17696207 [TBL] [Abstract][Full Text] [Related]
8. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia. Kumar S; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Litzow MR Bone Marrow Transplant; 2001 Nov; 28(10):951-6. PubMed ID: 11753550 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine. Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants. Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930 [TBL] [Abstract][Full Text] [Related]
11. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy. Cook G; Clark RE; Crawley C; Mackinnon S; Russell N; Thomson K; Pearce RM; Towlson K; Marks DI Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of allogeneic marrow transplantation for acute myelogenous leukemia after treatment with busulfan and cyclophosphamide. Bolaños-Meade J; Hartley E; Jones RJ Biol Blood Marrow Transplant; 2006 Mar; 12(3):366-7. PubMed ID: 16503506 [No Abstract] [Full Text] [Related]
14. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor. Chim CS; Lie AK; Liang R; Au WY; Kwong YL Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. Wong R; Shahjahan M; Wang X; Thall PF; De Lima M; Khouri I; Gajewski J; Alamo J; Couriel D; Andersson BS; Donato M; Hosing C; Komanduri K; Anderlini P; Molldrem J; Ueno NT; Estey E; Ippoliti C; Champlin R; Giralt S Biol Blood Marrow Transplant; 2005 Feb; 11(2):108-14. PubMed ID: 15682071 [TBL] [Abstract][Full Text] [Related]
16. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens. Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282 [TBL] [Abstract][Full Text] [Related]
17. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Mehta J; Powles R; Sirohi B; Treleaven J; Kulkarni S; Saso R; Tait D; Singhal S Bone Marrow Transplant; 2002 May; 29(10):853-9. PubMed ID: 12058235 [TBL] [Abstract][Full Text] [Related]
18. Comparative trials of chemotherapy and bone marrow transplantation in acute nonlymphocytic leukemia. Sullivan KM; Appelbaum FR Rinsho Ketsueki; 1990 May; 31(5):527-33. PubMed ID: 2118573 [No Abstract] [Full Text] [Related]
19. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. Kröger N; Brand R; van Biezen A; Cahn JY; Slavin S; Blaise D; Sierra J; Zander A; Niederwieser D; de Witte T; Bone Marrow Transplant; 2006 Jan; 37(2):183-9. PubMed ID: 16299545 [TBL] [Abstract][Full Text] [Related]
20. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]